Clinical Trials Directory

Trials / Completed

CompletedNCT02839239

Lactocare Baby Drops in Infants Colic

Role of Lactobacillus Rhamnosus (FloraActive™) 19070 and Lactobacillus Reuteri (FloraActive™) DSM 12246 in Infant Colic: a Controlled Dietary Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
168 (actual)
Sponsor
Biocare Copenhagen A/S · Industry
Sex
All
Age
4 Weeks – 12 Weeks
Healthy volunteers
Not accepted

Summary

The objective of this study is to determine an efficacy of the combination of L. rhamnosus 19070-2 (FloraActiveTM) and L. reuteri DSM 122460 (FloraActiveTM) in decreasing cry/fuss in infants aged 4 through 12 weeks with IC. The active group of infants will receive lactobacilli with vitamin D3 while the control group will receive vitamin D3 2 times daily as oil suspension for 28 days. Duration of infant fuss/cry will be measured at baseline and at the end of intervention to define a difference between the groups

Detailed description

There is accumulating interest in role of lactobacilli in decreasing cry and fuss in infant colic, the condition that affects around 1 of 4-5 infants. The interest for dietary supplementation has been evoked by a line of earlier studies, indicating that infants with colic had an increased number of gas-forming E.coli in the intestines and potential interference between lactobacilli and E.coli. Systematic review of evidence, based on the 6 randomized controlled dietary studies, conducted in Italy, Poland, Australia, Canada, and Finland, has concluded of the decrease of the mean time cry of infant by -55 minutes a day after the 3 weeks dietary course with lactobacilli . In the mentioned studies most commonly used lactobacilli were L. reuteri, however, the effect of combination of L. reuteri with other lactobacilli remains unknown.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDrops with lactobacilli and vitamin D3Oil suspension with lactobacilli and vitamin D3
DIETARY_SUPPLEMENTDrops with vitamin D3Oil suspension with vitamin D3

Timeline

Start date
2016-12-09
Primary completion
2018-01-15
Completion
2018-01-15
First posted
2016-07-20
Last updated
2018-01-18

Source: ClinicalTrials.gov record NCT02839239. Inclusion in this directory is not an endorsement.